tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DNTH Stock Latest News

Short Report: Dave & Busters bears boost exposure
The FlyShort Report: Dave & Busters bears boost exposure
21d ago
AAOI
DNTH
3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/17/2025, According to Top Analysts
26d ago
KO
DNTH
Dianthus initiated with a Buy at Clear Street
PremiumThe Fly
Dianthus initiated with a Buy at Clear Street
27d ago
DNTH
Dianthus price target raised to $65 from $52 at Stifel
PremiumThe Fly
Dianthus price target raised to $65 from $52 at Stifel
1M ago
DNTH
Dianthus price target raised to $44 from $42 at Wedbush
PremiumThe Fly
Dianthus price target raised to $44 from $42 at Wedbush
1M ago
DNTH
Dianthus Therapeutics Raises $270M Through Stock Offering
PremiumCompany AnnouncementsDianthus Therapeutics Raises $270M Through Stock Offering
1M ago
8K
DNTH
Dianthus 6.49M share Secondary priced at $33.00
Premium
The Fly
Dianthus 6.49M share Secondary priced at $33.00
1M ago
DNTH
Dianthus price target raised to $63 from $56 at Raymond James
Premium
The Fly
Dianthus price target raised to $63 from $56 at Raymond James
1M ago
DNTH
Dianthus price target raised to $67 from $50 at Baird
PremiumThe Fly
Dianthus price target raised to $67 from $50 at Baird
1M ago
DNTH
Closing Bell Movers: Nebius up over 40% on Microsoft deal
PremiumThe Fly
Closing Bell Movers: Nebius up over 40% on Microsoft deal
1M ago
PL
APP
Dianthus announces $150M common stock offering
PremiumThe Fly
Dianthus announces $150M common stock offering
1M ago
DNTH
Dianthus price target raised to $100 from $92 at Guggenheim
PremiumThe Fly
Dianthus price target raised to $100 from $92 at Guggenheim
1M ago
DNTH
EchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
PremiumThe FlyEchoStar sells spectrum licenses to SpaceX, StubHub to launch IPO: Morning Buzz
1M ago
BA
PL
Promising Phase II Results and Market Potential Drive Buy Rating for Dianthus Therapeutics
Premium
Ratings
Promising Phase II Results and Market Potential Drive Buy Rating for Dianthus Therapeutics
1M ago
DNTH
Promising Clinical Data and Strategic Plans Support Buy Rating for Dianthus Therapeutics
Premium
Ratings
Promising Clinical Data and Strategic Plans Support Buy Rating for Dianthus Therapeutics
1M ago
DNTH
Dianthus gMG data has positive read through to other indications, says Jefferies
PremiumThe Fly
Dianthus gMG data has positive read through to other indications, says Jefferies
1M ago
DNTH
Dianthus price target raised to $72 at Evercore after ‘bull case outcome’
PremiumThe Fly
Dianthus price target raised to $72 at Evercore after ‘bull case outcome’
1M ago
DNTH
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
PremiumThe Fly
Morning Movers: EchoStar jumps following $17B spectrum deal with SpaceX
1M ago
EME
DNTH
Dianthus Therapeutics Reports Positive Phase 2 Trial Results
PremiumCompany Announcements
Dianthus Therapeutics Reports Positive Phase 2 Trial Results
1M ago
8K
DNTH
Promising Phase 2 Results and Market Potential Drive Buy Rating for Dianthus Therapeutics’ Claseprubart
PremiumRatingsPromising Phase 2 Results and Market Potential Drive Buy Rating for Dianthus Therapeutics’ Claseprubart
1M ago
DNTH
Dianthus Therapeutics: Promising Phase II Results and Expanding Market Potential Justify Buy Rating
Premium
Ratings
Dianthus Therapeutics: Promising Phase II Results and Expanding Market Potential Justify Buy Rating
1M ago
DNTH
Dianthus announces data from Phase 2 MaGic trial of claseprubart
Premium
The Fly
Dianthus announces data from Phase 2 MaGic trial of claseprubart
1M ago
DNTH

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >